Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Direxion S&P Biotech Bull 3X (NY: LABU)
58.87 USD  -1.58 (-2.61%)
Official Closing Price  /  Updated: 8:00 PM EST, Jan 17, 2020  /  Add to My Watchlist      
View: Quote News
Fund Overview
Direxion S&P Biotech Bull 3X
Sector
Exchange Traded NY
Net Assets 253.82M
Inception Date
Related Funds
Quote
Price 58.87
Volume 1,304,700
Last Trade Jan 17, 8:00pm
Change (%)
-1.58 (-2.61%)
Prev. Close 60.45
YTD %
+4.29%
Dividend Yield 0.19%
Performance
YTD
+2.42 (4.29%)
1 Month
-0.16 (-0.27%)
3 Month
+25.41 (75.94%)
6 Month
+12.92 (28.12%)
1 Year
+10.57 (21.88%)
Chart
Charting
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
LABU February 28th Options Begin Trading
Investors in Direxion Shares Exchange Traded Fund Trust - Direxion Daily S&P Biotech Bull 3X Shares (LABU) saw new options begin trading today, for the February 28th expiration. At Stock Options... Read More
from Market News Video
February 2020 Options Now Available For Direxion Shares Exchange Traded Fund Trust - Direxion Daily S&P Biotech Bull 3X Shares (LABU)
Investors in Direxion Shares Exchange Traded Fund Trust - Direxion Daily S&P Biotech Bull 3X Shares (LABU) saw new options begin trading today, for the February 2020 expiration. At Stock Options... Read More
from Market News Video
Top News
More News
Consider These 2 Leveraged Biotech ETFs to Ride The M&A Trend
The biotech and healthcare space has been on fire lately. The healthcare space is witnessing a Mergers and Acquisitions wave recently that has achieved an impressive $342 billion in new deal activity... Read More
from ETF Trends
Rally Continues Heading Into Shorten Post-Thanksgiving Session
Volume has not gone gangbusters, but given we are in a holiday week it really is no surprise turnover is light. Read More
from Blogs - TalkMarkets
UGAZ: Time To Buy?
Is it time to buy natural gas ETF UGAZ? Read More
from Blogs - TalkMarkets
Sell on the Pop Prospects: November 13 Edition
Here is a look at ETFs that currently offer attractive short selling opportunities. The ETFs included in this list are rated as sell candidates for two reasons. First, each of these funds is deemed to... Read More
from ETFdb
Sell on the Pop Prospects: September 18 Edition
Here is a look at ETFs that currently offer attractive short selling opportunities. The ETFs included in this list are rated as sell candidates for two reasons. First, each of these funds is deemed to... Read More
from ETFdb
First Week of September 20th Options Trading For Direxion Shares Exchange Traded Fund Trust - Direxion Daily S&P Biotech Bull 3X Shares (LABU)
Investors in Direxion Shares Exchange Traded Fund Trust - Direxion Daily S&P Biotech Bull 3X Shares (LABU) saw new options begin trading this week, for the September 20th expiration. At Stock Options... Read More
from Market News Video
These Are The Leveraged ETFs At Play When Trade War Worries Strike
The U.S.-China trade war is more than 18 months old. And in that time the conflict has taken a toll on stocks across the world and put ... Read More
from Benzinga
Sell on the Pop Prospects: July 24 Edition
Here is a look at ETFs that currently offer attractive short selling opportunities. The ETFs included in this list are rated as sell candidates for two reasons. First, each of these funds is deemed to... Read More
from ETFdb
Trading Eye For The Rate-Cut Guy
If monetary policy hawks were hoping to get a reprieve from the rising sentiment of an upcoming rate cut, Jerome Powell’s ... Read More
from Benzinga
Sell on the Pop Prospects: June 26 Edition
Here is a look at ETFs that currently offer attractive short selling opportunities. The ETFs included in this list are rated as sell candidates for two reasons. First, each of these funds is deemed to... Read More
from ETFdb
A Beloved Biotech ETF Could Lure Traders Again
With biotechnology stocks and the related exchange-traded funds recently showing some signs of life, it could be just a matter of time ... Read More
from Benzinga
A Big Week for Betting On the CURE for Cancer
One of the biggest healthcare conferences of the year just ended—the American Society of Clinical Oncology Annual Meeting. Since ASCO was founded in 1964, funding for cancer research has gone from less... Read More
from ETF Trends
It's Time To Consider Leveraged Healthcare ETFs
For traders using leveraged sector exchange-traded funds, one key to successfully using these products in the short-term fashion in which they are intended is to treat leveraged ETFs as event-driven... Read More
from Blogs - TalkMarkets
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.